Drug intelligence / Profile preview

SilvoGuard

Development stage
Unknown
Lead developer
WeInnovate Biosolutions
Modality
Nanoparticles → Drug Delivery Systems
Administration
Urethral, Topical
01

Overview

SilvoGuard is a range of antimicrobial medical devices developed by WeInnovate Biosolutions, an Indian startup. These devices, which include Foley catheters, utilize the company's patented NanoAgCide technology—a colloidal silver nanoparticle-based solution. The technology is integrated into the device material to provide a sustained release of active silver ions. These ions exert broad-spectrum antimicrobial activity by disrupting bacterial cell membranes, interfering with DNA replication, and binding to essential bacterial proteins, thereby preventing bacterial adhesion and the formation of biofilms. SilvoGuard is primarily used in healthcare settings to prevent hospital-acquired infections (HAIs), such as catheter-associated urinary tract infections (CAUTI).

Brand names
SilvoGuard
Other names
NanoAgCide
02

Targets

Neuraminidase

Beyond the preview

Go deeper on SilvoGuard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SilvoGuard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call